PRAECIS PHARMACEUTICALS INCORPORATED To Announce First Quarter Financial Results on Friday, May 5, 2006
April 28 2006 - 7:30AM
Business Wire
PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS), today
announced that it will report First Quarter 2006 financial results
on Friday, May 5, 2006, before the financial markets open. Company
management will host a conference call beginning at 9:00 a.m., EDT,
with members of the investment community. The Company's conference
call may be accessed live by visiting PRAECIS' website at
http://www.praecis.com under "Investors" and "Webcast Live."
Interested parties also may listen to a replay of the call
beginning Friday, May 5, at 12:00 Noon, EDT, until midnight Friday,
May 12, by calling 888-203-1112 or 719-457-0820, and entering the
passcode 6614522. PRAECIS PHARMACEUTICALS INCORPORATED is a
biopharmaceutical company focused on the discovery and development
of novel compounds that have the potential to address unmet medical
needs or improve existing therapies. PRAECIS has a novel MetAP-2
inhibitor, PPI-2458, in clinical development for cancer
indications, including non-Hodgkin's lymphoma and solid tumors, as
well as an innovative drug discovery technology, DirectSelect(TM),
which enables the generation and practical use of ultra-large
libraries for the discovery of orally active compounds for drug
development. PRAECIS has received approval to market Plenaxis(R) in
both the United States and Germany.
Praecis (NASDAQ:PRCS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Praecis (NASDAQ:PRCS)
Historical Stock Chart
From Aug 2023 to Aug 2024